Popular Tags

398 Blogs found.
  • Oct 22 2026

    29 3 0 0/5

    SpaceX merger commentary is arguably the biggest thing on the minds of Tesla investors right now — and Musk had nothing new to offer on Wednesday.

  • Oct 22 2026

    24 1 0 0/5

    Meta’s core advertising business delivered a strong quarter, but investors are eyeing promising new businesses around the Muse personal assistant

  • Oct 22 2026

    13 0 0 0/5

    Wall Street is all abuzz over a possible merger between Tesla and SpaceX. But there is a high probability that such a merger would be a bad idea.

  • Oct 22 2026

    4 0 0 0/5

    Oil flows out of the Persian Gulf in October nearly returned to levels seen before the start of the Iran war, but traders remain wary about a fragile recovery.

  • Oct 22 2026

    12 0 0 0/5

    Investors have pushed the healthcare sector to a record high, and some favored stocks have high projected revenue growth rates through 2028.

  • Oct 21 2026

    9 0 0 0/5

    The president’s statement comes as a voter backlash against the facilities intensifies ahead of the midterm elections.

  • Oct 21 2026

    14 0 0 0/5

    As Elon Musk aims to increase SpaceX’s computing capacity exponentially, he’ll face challenges related to funding, power supply and simply securing sufficient chips.

  • Oct 21 2026

    15 0 0 0/5

    Social Security is looking to reverse an initially slow uptake on Trump accounts

  • Oct 21 2026

    7 0 0 0/5

    Agricultural markets around the world are already dealing with record-high diesel prices and high fertilizer costs. A “super” El Niño is almost guaranteed to make matters worse for farmers and consumers.

  • Oct 21 2026

    12 0 0 0/5

    Private insurance costs way more for the same results — or worse.

  • Oct 21 2026

    5 0 0 0/5

    For investors worried that the runaway artificial-intelligence trade might be about to hit the skids, prediction markets are already starting to reflect that anxiety.

  • Oct 21 2026

    1 0 0 0/5

    Moderna is one of the hottest stocks of the year because of its custom cancer treatment. Full Phase 3 data are set to be revealed this weekend.